TY - STD TI - UNAIDS. UNAIDS Issues New Fast-Track Strategy to End AIDS by 2030. Joint United Nations Programme on HIV/AIDS (UNAIDS); 2014. https://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf. Accessed 10 Sept 2019. UR - https://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf ID - ref1 ER - TY - JOUR AU - Dalhatu, I. PY - 2016 DA - 2016// TI - Outcomes of Nigeria’s HIV/aids treatment program for patients initiated on antiretroviral treatment between 2004–2012 JO - PLoS ONE VL - 11 ID - Dalhatu2016 ER - TY - STD TI - NACA. National Agency for the Control of AIDS (NACA). Nigeria UNGASS Report In: Strategic planning and research. NACA, Abuja; 2007. https://naca.gov.ng/wp-content/uploads/2016/11/NACA-2011-ANNUAL-REPORT-FINAL-DRAFT_06062012-2011REPORT.pdf. Accessed 10 Sept 2019. UR - https://naca.gov.ng/wp-content/uploads/2016/11/NACA-2011-ANNUAL-REPORT-FINAL-DRAFT_06062012-2011REPORT.pdf ID - ref3 ER - TY - STD TI - UNAIDS. UNAIDS. Epidemiological factsheet Geneva: UNAIDS; 2019. https://www.unaids.org/en/regionscountries/countries/nigeria. Accessed 10 Sept 2019. UR - https://www.unaids.org/en/regionscountries/countries/nigeria ID - ref4 ER - TY - STD TI - WHO. Global update on HIV treatment 2013. Glob. Updat. HIV Treat. 2013 results, impact Oppor., no. June, p. 7; 2013. ID - ref5 ER - TY - JOUR AU - Stafford, K. A. PY - 2019 DA - 2019// TI - Evaluation of the clinical outcomes of the test and treat strategy to implement treat all in Nigeria: results from the Nigeria multi-center ART study JO - PLoS ONE VL - 14 ID - Stafford2019 ER - TY - STD TI - UNAIDS. New survey results indicate that Nigeria has an HIV prevalence of 1.4%—Nigeria | ReliefWeb; 2019. https://reliefweb.int/report/nigeria/new-survey-results-indicate-nigeria-has-hiv-prevalence-14. Accessed 10 Sept 2019. UR - https://reliefweb.int/report/nigeria/new-survey-results-indicate-nigeria-has-hiv-prevalence-14 ID - ref7 ER - TY - JOUR AU - Haas, A. D. PY - 2015 DA - 2015// TI - Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis JO - Lancet HIV VL - 2 ID - Haas2015 ER - TY - JOUR PY - 2016 DA - 2016// TI - Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study JO - Lancet Infect Dis VL - 16 ID - ref9 ER - TY - JOUR AU - Gregson, J. PY - 2017 DA - 2017// TI - Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study JO - Lancet Infect Dis VL - 17 ID - Gregson2017 ER - TY - JOUR AU - Gupta, R. K. PY - 2009 DA - 2009// TI - Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis JO - Lancet Infect Dis VL - 9 ID - Gupta2009 ER - TY - BOOK PY - 2019 DA - 2019// TI - WHO | HIV drug resistance report 2019 PB - WHO CY - Geneva ID - ref12 ER - TY - JOUR AU - Gupta, R. K. PY - 2018 DA - 2018// TI - HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis JO - Lancet Infect Dis VL - 18 ID - Gupta2018 ER - TY - STD TI - FMOH. National Guidelines for HIV Prevention Treatment and Care. Abuja; 2016. ID - ref14 ER - TY - JOUR AU - Meloni, S. T. PY - 2016 DA - 2016// TI - Long-term outcomes on antiretroviral therapy in a large scale-up program in Nigeria JO - PLoS ONE VL - 11 ID - Meloni2016 ER - TY - JOUR AU - Abubakar, A. PY - 2015 DA - 2015// TI - Improved performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 assay over amplicor monitor version 1.5 in the quantification of HIV-1 RNA viral load in Abuja, Nigeria JO - Curr HIV Res VL - 13 ID - Abubakar2015 ER - TY - JOUR AU - Kazooba, P. AU - Mayanja, B. N. AU - Levin, J. AU - Masiira, B. AU - Kaleebu, P. PY - 2018 DA - 2018// TI - Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004–2011 JO - Pan Afr Med J VL - 29 ID - Kazooba2018 ER - TY - JOUR AU - Etiebet, M. A. A. PY - 2013 DA - 2013// TI - Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy JO - Aids VL - 27 ID - Etiebet2013 ER - TY - JOUR AU - Kayondo, J. K. PY - 2015 DA - 2015// TI - Intrapatient evolutionary dynamics of human immunodeficiency virus type 1 in individuals undergoing alternative treatment strategies with reverse transcriptase inhibitors JO - AIDS Res Hum Retroviruses VL - 31 ID - Kayondo2015 ER - TY - JOUR AU - Rawizza, H. E. PY - 2011 DA - 2011// TI - Immunologic criteria are poor predictors of virologic outcome: implications for hiv treatment monitoring in resource-limited settings JO - Clin Infect Dis VL - 53 ID - Rawizza2011 ER - TY - JOUR AU - Palladino, C. PY - 2013 DA - 2013// TI - Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique JO - PLoS ONE. VL - 8 ID - Palladino2013 ER - TY - JOUR AU - Anude, C. J. PY - 2013 DA - 2013// TI - Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria JO - BMC Infect Dis VL - 13 ID - Anude2013 ER - TY - JOUR AU - Ndagijimana Ntwali, J. D. PY - 2019 DA - 2019// TI - Viral load detection and management on first line ART in rural Rwanda JO - BMC Infect Dis VL - 19 ID - Ndagijimana Ntwali2019 ER - TY - JOUR AU - Fox, M. P. PY - 2012 DA - 2012// TI - Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa JO - JAIDS J Acquir Immune Defic Syndr VL - 60 ID - Fox2012 ER - TY - JOUR AU - Kiweewa, F. PY - 2019 DA - 2019// TI - HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study JO - PLoS ONE VL - 14 ID - Kiweewa2019 ER - TY - JOUR AU - Agaba, P. PY - 2014 DA - 2014// TI - Patients who present late to HIV care and associated risk factors in Nigeria JO - HIV Med. VL - 15 ID - Agaba2014 ER - TY - JOUR AU - Rodriguez-Hart, C. PY - 2018 DA - 2018// TI - The synergistic impact of sexual stigma and psychosocial well-being on HIV testing: a mixed-methods study among Nigerian men who have sex with men JO - AIDS Behav VL - 22 ID - Rodriguez-Hart2018 ER - TY - JOUR AU - Crowell, T. A. PY - 2017 DA - 2017// TI - Stigma, access to healthcare, and HIV risks among men who sell sex to men in Nigeria JO - J Int AIDS Soc VL - 20 ID - Crowell2017 ER - TY - JOUR AU - May, M. PY - 2010 DA - 2010// TI - Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes JO - Lancet (London, England) VL - 376 ID - May2010 ER - TY - JOUR AU - Lihana, R. W. PY - 2012 DA - 2012// TI - Update on HIV-1 diversity in Africa: a decade in review JO - AIDS Rev VL - 14 ID - Lihana2012 ER - TY - JOUR AU - Li, Y. PY - 2019 DA - 2019// TI - Genetic clustering analysis for HIV infection among men who have sex with men in Nigeria: implications for intervention JO - AIDS UR - https://doi.org/10.1097/qad.0000000000002409 DO - 10.1097/qad.0000000000002409 ID - Li2019 ER - TY - JOUR AU - Billings, E. PY - 2019 DA - 2019// TI - New subtype B Containing HIV-1 circulating recombinant of sub-Saharan Africa origin in Nigerian men who have sex with men JO - J Acquir Immune Defic Syndr VL - 81 UR - https://doi.org/10.1097/qai.0000000000002076 DO - 10.1097/qai.0000000000002076 ID - Billings2019 ER - TY - JOUR AU - Hemelaar, J. PY - 2019 DA - 2019// TI - Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis JO - Lancet Infect Dis VL - 19 UR - https://doi.org/10.1016/s1473-3099(18)30647-9 DO - 10.1016/s1473-3099(18)30647-9 ID - Hemelaar2019 ER - TY - JOUR AU - Rhee, S. -. Y. PY - 2016 DA - 2016// TI - HIV-1 protease, reverse transcriptase, and integrase variation JO - J Virol VL - 90 ID - Rhee2016 ER - TY - JOUR AU - Boender, T. S. PY - 2015 DA - 2015// TI - Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis JO - Clin Infect Dis VL - 61 ID - Boender2015 ER - TY - JOUR AU - Goodall, R. L. PY - 2017 DA - 2017// TI - Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa JO - J Antimicrob Chemother VL - 72 ID - Goodall2017 ER - TY - JOUR AU - Inzaule, S. C. PY - 2018 DA - 2018// TI - Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance JO - Sci. Rep. VL - 8 ID - Inzaule2018 ER -